273 related articles for article (PubMed ID: 12124870)
1. Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts.
Leask A; Abraham DJ; Finlay DR; Holmes A; Pennington D; Shi-Wen X; Chen Y; Venstrom K; Dou X; Ponticos M; Black C; Bernabeu C; Jackman JK; Findell PR; Connolly MK
Arthritis Rheum; 2002 Jul; 46(7):1857-65. PubMed ID: 12124870
[TBL] [Abstract][Full Text] [Related]
2. Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.
Morris E; Chrobak I; Bujor A; Hant F; Mummery C; Ten Dijke P; Trojanowska M
J Cell Physiol; 2011 Dec; 226(12):3340-8. PubMed ID: 21344387
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling.
Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H
Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162
[TBL] [Abstract][Full Text] [Related]
4. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
Man XY; Finnson KW; Baron M; Philip A
Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
[TBL] [Abstract][Full Text] [Related]
5. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
[TBL] [Abstract][Full Text] [Related]
6. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
[TBL] [Abstract][Full Text] [Related]
7. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
[TBL] [Abstract][Full Text] [Related]
8. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
9. Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts.
Makino K; Jinnin M; Aoi J; Hirano A; Kajihara I; Makino T; Sakai K; Fukushima S; Inoue Y; Ihn H
J Invest Dermatol; 2013 Jan; 133(1):110-9. PubMed ID: 22832484
[TBL] [Abstract][Full Text] [Related]
10. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.
Tomcik M; Palumbo-Zerr K; Zerr P; Sumova B; Avouac J; Dees C; Distler A; Becvar R; Distler O; Schett G; Senolt L; Distler JH
Ann Rheum Dis; 2016 Mar; 75(3):609-16. PubMed ID: 25603829
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype.
Kawakami T; Ihn H; Xu W; Smith E; LeRoy C; Trojanowska M
J Invest Dermatol; 1998 Jan; 110(1):47-51. PubMed ID: 9424086
[TBL] [Abstract][Full Text] [Related]
12. TGF beta--a role in systemic sclerosis?
Cotton SA; Herrick AL; Jayson MI; Freemont AJ
J Pathol; 1998 Jan; 184(1):4-6. PubMed ID: 9582519
[TBL] [Abstract][Full Text] [Related]
13. Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts.
Yamakage A; Kikuchi K; Smith EA; LeRoy EC; Trojanowska M
J Exp Med; 1992 May; 175(5):1227-34. PubMed ID: 1314885
[TBL] [Abstract][Full Text] [Related]
14. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
Zerr P; Palumbo-Zerr K; Huang J; Tomcik M; Sumova B; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2016 Jan; 75(1):226-33. PubMed ID: 25180292
[TBL] [Abstract][Full Text] [Related]
15. Role of endoglin in fibrosis and scleroderma.
Maring JA; Trojanowska M; ten Dijke P
Int Rev Cell Mol Biol; 2012; 297():295-308. PubMed ID: 22608563
[TBL] [Abstract][Full Text] [Related]
16. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
Ihn H; Yamane K; Kubo M; Tamaki K
Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
[TBL] [Abstract][Full Text] [Related]
17. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of scleroderma. Collagen.
Jimenez SA; Hitraya E; Varga J
Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
20. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
